Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares stood at 1.17 million during the latest session, with the company’s beta value hitting 3.45. At the last check
Sagimet Biosciences Inc (NASDAQ:SGMT) has a beta value of 3.36 and has seen 1.04 million shares traded in the last trading session. The company, currently
Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 3.37. At the close of
In the last trading session, 1.7 million Sagimet Biosciences Inc (NASDAQ:SGMT) shares changed hands as the company’s beta touched 3.33. With the company’s per share
Sagimet Biosciences Inc (NASDAQ:SGMT) has a beta value of 2.12 and has seen 1.31 million shares traded in the last trading session. The company, currently
During the last session, Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares were 1.19 million, with the beta value of the company hitting 2.23. At the end
Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares stood at 3.17 million during the last session, with the company’s beta value hitting 2.42. At the close of
In the latest trading session,, 0.55 million Sagimet Biosciences Inc (NASDAQ:SGMT) shares changed hands as the company’s beta touched 2.29. With the company’s most recent
Sagimet Biosciences Inc (NASDAQ:SGMT) has a beta value of 2.24 and has seen 14.26 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne